Navigation Links
PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo

LAKE FOREST, Ill., May 17, 2012 /PRNewswire/ -- Amy Langan, Vice President of Marketing and Business Development, announced that PharMEDium will highlight its enhanced labeling for sterile intravenous compounded ICU Services at the National Teaching Institute (NTI) and Critical Care Exposition, May 19-24, 2012 in Orlando, Florida.


Ms. Langan invites critical care professionals to visit Booth #2668 to see how the enhanced labels help clinicians and pharmacy staff with easier drug and dose recognition when stocking, retrieving, and administering compounded services from PharMEDium.  Onsite PharMEDium associates will showcase the functionality and appearance of the enhanced labels and packaging, which are resultant of PharMEDium's ongoing commitment to patient safety, quality and innovation.

"Attendees at the NTI and Critical Care Exposition anticipate seeing new ideas, approaches and innovations designed to help them provide patient safety and quality of care for critically ill patients," stated David N. Jonas, CEO and Chairman of the Board.   "As the key educational and informational event for critical care caregivers, this meeting is an ideal forum for PharMEDium to present our new and enhanced labeling for ICU services."

At the 2011 Chicago exposition, PharMEDium conducted market research with over 1000 critical care nurses, enabling PharMEDium to gain a broader understanding of the medication administration challenges critical care nurses face.  The findings were the foundation for several of the enhancements now in the market. For example, service being delivered with new labels includes Phenylephrine, Norepinephrine and Vasopressin ready-to-use compounded sterile preparations.  David N. Jonas, PharMEDium Chairman and CEO, added, "We have received positive feedback about the labeling enhancements.  We're enthusiastic to be a part of this professional group and PharMEDium is proud to be a corporate sponsor of the American Association of Critical Care Nurses."

About PharMEDium
PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium® network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and federal regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit


Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Adds O.R. Medication Verification System
2. PharMEDiums Technology Helps Hospital Pharmacists Ensure Safety
3. PharMEDium Unveils Drug Shortage and Usage Updates on New Website with Focus on Patient Safety
4. PharMEDium Services, LLC Receives U.S. Patent 7,918,830 Entitled Safety Device for Drug Delivery Devices and Containers
5. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
6. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
7. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
8. PharMEDium Elects William R. Spalding to Board of Directors
9. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
10. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
11. Delcath Highlights First Quarter 2012 And Recent Accomplishments
Post Your Comments:
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... 2015 --> --> ... to find optimal contrast weighting of MRI for patients ... signed a research agreement with SyntheticMR in order to use ... it is possible to generate multiple contrast images from a ... has left, thus making it possible to both fine tune ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... most successful and prominent nonprofit healthcare organizations in the country. They have overseen ... various organizations, and helped advance the healthcare industry as a whole through their ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term Support) ... supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... Jobs in ... by healthcare professionals and offered by healthcare staffing agency Aureus Medical Group . ... the month of October 2015 among those searching for healthcare jobs through the company’s ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack ... trailer titles work with any font, giving users limitless opportunities to stylize and ...
Breaking Medicine News(10 mins):